Evidence map›Paper›PMID 38688245›Full record

ArticleNephron2024

Remote Surveillance Technology of Dialysis Arteriovenous Access: Retrospective Evaluation in a UK Renal Centre.

Alshymaa Rafiek Eltahan, Zulfikar Pondor, Rosemary L Donne, David Lewis, Maharajan Raman, Paul Hinchliffe, Jan Cowperthwaite, Dimitrios Poulikakos

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nephron, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alshymaa Rafiek EltahanRenal Department, Northern Care Alliance NHS Foundation Trust, Salford Care Organization, Greater Manchester, UK, alshymaaeltahan@gmail.com.
Zulfikar PondorRenal Department, Northern Care Alliance NHS Foundation Trust, Salford Care Organization, Greater Manchester, UK.
Rosemary L DonneRenal Department, Northern Care Alliance NHS Foundation Trust, Salford Care Organization, Greater Manchester, UK.
David LewisRenal Department, Northern Care Alliance NHS Foundation Trust, Salford Care Organization, Greater Manchester, UK.
Maharajan RamanRenal Department, Northern Care Alliance NHS Foundation Trust, Salford Care Organization, Greater Manchester, UK.
Paul HinchliffeRenal Department, Northern Care Alliance NHS Foundation Trust, Salford Care Organization, Greater Manchester, UK.
Jan CowperthwaiteRenal Department, Northern Care Alliance NHS Foundation Trust, Salford Care Organization, Greater Manchester, UK.
Dimitrios PoulikakosRenal Department, Northern Care Alliance NHS Foundation Trust, Salford Care Organization, Greater Manchester, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEarly identification of dysfunctional arteriovenous haemodialysis (HD) vascular access (VA) is important for timely referral and intervention.

methodWe retrospectively calculated VA risk score using Vasc-Alert surveillance software technology from HD treatment sessions in 2 satellite HD units over 18 months. We included in the analysis HD patients dialysing with arteriovenous fistula or graft (AVF/G) with available Vasc-Alert data for≥ 2 months. For group one (eventful) that included patients who developed vascular access thrombosis or stenosis over the study period, we collected Vasc-Alert risk score 2 months prior to the event and, for group two (uneventful), over 5 consecutive months. Vasc-Alert technology utilises routinely collected data during HD to calculate VA risk score and triggers an alert if the score is ≥7 in 3 consecutive dialysis sessions. Patients with >2 alerts (vascular access score ≥7) per month were considered to have positive alerts.

resultsFrom 140 HD patients, 81 patients dialysed via AVF/G. 77/81 had available Vasc-Alert data and were included in the final analysis. Out of 17 eventful patients, 11 (64.7%) had positive alerts 2 months prior to the vascular event. Out of the 60 patients without vascular events, 20 patients (33.3%) had positive alert. Vasc-Alert's sensitivity and specificity for vascular events were 64.7% and 66.6%, respectively. Within the 6 patients with thrombosed access, 2 patients (33.3%) detected by Vasc-Alert were not detected with clinical monitoring.

conclusionVascular access risk score can be a useful non-invasive vascular access surveillance method to assist clinical decision making.

Indexed as

Arteriovenous Shunt, SurgicalRenal DialysisAdultAgedFemaleHumansKidney Failure, ChronicMaleMiddle AgedRetrospective StudiesThrombosisUnited KingdomArteriovenous fistula/graftStenosisThrombosisVasc-Alert technologyVascular access surveillance

Identifiers

PMID38688245
PMCPMC11332309

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.